Abstract:Visual hallucinations are frequent, disabling complications of advanced Parkinson's disease, but their neuroanatomical basis is incompletely understood. Previous structural brain magnetic resonance imaging studies suggest volume loss in the mesial temporal lobe and limbic regions in subjects with Parkinson's disease with visual hallucinations, relative to those without visual hallucinations. However, these studies have not always controlled for the presence of cognitive impairment or dementia, which are common co-morbidities of hallucinations in Parkinson's disease and whose neuroanatomical substrates may involve mesial temporal lobe and limbic regions. Therefore, we used structural magnetic resonance imaging to examine grey matter atrophy patterns associated with visual hallucinations, comparing Parkinson's disease hallucinators to Parkinson's disease non-hallucinators of comparable cognitive function. We studied 50 subjects with Parkinson's disease: 25 classified as current and chronic visual hallucinators and 25 as non-hallucinators, who were matched for cognitive status (demented or non-demented) and age (± 3 years). Subjects underwent (i) clinical evaluations; and (ii) brain MRI scans analysed using whole-brain voxel-based morphometry techniques. Clinically, the Parkinson's disease hallucinators did not differ in their cognitive classification or performance in any of the five assessed cognitive domains, compared with the non-hallucinators. The Parkinson's disease groups also did not differ significantly in age, motor severity, medication use or duration of disease. On imaging analyses, the hallucinators, all of whom experienced visual hallucinations, exhibited grey matter atrophy with significant voxel-wise differences in the cuneus, lingual and fusiform gyri, middle occipital lobe, inferior parietal lobule, and also cingulate, paracentral, and precentral gyri, compared with the non-hallucinators. Grey matter atrophy in the hallucinators occurred predominantly in brain regions responsible for processing visuoperceptual information including the ventral 'what' and dorsal 'where' pathways, which are important in object and facial recognition and identification of spatial locations of objects, respectively. Furthermore, the structural brain changes seen on magnetic resonance imaging occurred independently of cognitive function and age. Our findings suggest that when hallucinators and non-hallucinators are similar in their cognitive performance, the neural networks involving visuoperceptual pathways, rather than the mesial temporal lobe regions, distinctively contribute to the pathophysiology of visual hallucinations and may explain their predominantly visual nature in Parkinson's disease. Identification of distinct structural MRI differences associated with hallucinations in Parkinson's disease may permit earlier detection of at-risk patients and ultimately, development of therapies specifically targeting hallucinations and visuoperceptive functions.

Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations

Grey Matter Volume Reduction in the Frontotemporal Cortex Associated with Persistent Verbal Auditory Hallucinations in Chinese Patients with Chronic Schizophrenia: Insights from a 3 T Magnetic Resonance Imaging Study

Volumetric MRI Correlates of Persistent Auditory Verbal Hallucinations and Olfactory Identification Impairment in Chronic Schizophrenia: A Cross-Sectional Study

Functional and structural brain network correlates of visual hallucinations in Lewy body dementia

Global brain analysis of minor hallucinations in Parkinson's disease using EEG and MRI data

Global Brain Analysis of Minor Hallucinations in Parkinson’s Disease Using EEG and MRI Data

A Multimodal Neuroimaging and Neuropsychological Study of Visual Hallucinations in Alzheimer's Disease

Visual hallucinations in Parkinson's disease are associated with thinning of the inner retina

Differences in Cortical Thickness in Schizophrenia Patients with and Without Auditory Verbal Hallucinations

An attentional and working memory theory of hallucination vulnerability in frontotemporal dementia

Cholinergic deficiency in Parkinson's disease patients with visual hallucinations

Visual hallucinations in Parkinson's disease: spotlight on central cholinergic dysfunction

Deficit in parietal memory network underlies auditory hallucination: a longitudinal study

Visual hallucinations in Parkinson's disease: a review and phenomenological survey

Clinical Features of Visual Hallucination and Its Associated Factors in Parkinson’s Disease

Cognitive Dysfunction and Cortical Structural Abnormalities in First-Episode Drug-Naïve Schizophrenia Patients with Auditory Verbal Hallucination

Visual hallucinations in Lewy body disease: pathophysiological insights from phenomenology

Visual hallucinations in Alzheimer's disease do not seem to be associated with chronic hypoperfusion of to visual processing areas V2 and V3 but may be associated with reduced cholinergic input to these areas

Clinical analysis of hallucinations in patients with Parkinson's disease

Structural brain differences in patients with schizophrenia spectrum disorders with and without auditory verbal hallucinations

Reciprocal deterioration of visual and auditory hallucinations in schizophrenia presents V-shaped cognition impairment and widespread reduction in brain gray matter-A pilot study